Top 50 Life Science VC (Venture Capital) Funds in China in September 2025
A list of 50 VC (Venture Capital) funds that invest in Life science startups based in China. We rank investors based on the number of investments they made in Life science companies from China. We update this investor list every month.Top 50 Life Science VC (Venture Capital) Funds in China in September 2025
Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential.They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many yearsof remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.
Show more
Investment focus
- Medical, Biotechnology, Health Care
- Seed, Funding Round, Series A
- China, United States, United Kingdom
Portfolio highlights
- Rhino Medical — Rhino Medical develops advanced technologies with independent intellectual property rights. The founding team has rich experience in R&D, marketing, and clinical. On the basis of benchmarking imported phacoemulsification instruments and vitrectomy instruments
- Tuanxiang Pharmaceutical — Tuanxiang Pharmaceutical is an innovative drug research and development company that combines traditional new drug research and development with the use of the world's leading unique phase separation technology.
- Rapafusyn Pharmaceuticals — Rapafuysn is pioneering RapaGlues - a modality of non-degrading molecular glues that addresses hard-to-drug targets.
We help founders build enduring companies.
Show more
Investment focus
- Health Care, Biotechnology, Artificial Intelligence
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- MarqVision — Effortlessly discover and remove counterfeits to protect your sales and reputation.
- Midas — Midas is the first neobroker of Turkey, providing zero commission Turkish and American stocks.
- Yunzhou Zhiwei — Yunzhou Zhiwei is a high-tech startup focused on serving large-scale equipment maintenance industries such as aviation, aerospace, shipbuilding, and rail transit. It leverages smart maintenance concepts and advanced digital technologies to make complex equipment maintenance more efficient and lean. The company drives industrial transformationtoward intelligent maintenance, helping enterprises enhance growth, efficiency, and operational excellence.
Founded in 2006, Qiming Venture Partners is a leading China venture capital firm with offices in Shanghai, Beijing, Suzhou, Hong Kong in China, and Singapore.Currently, Qiming Venture Partners manages eleven US Dollar funds and seven RMB funds with $9.5 billion in capital raised. Since our establishment, we have invested in outstanding companiesin the Technology and Consumer (T&C) and Healthcare industries at the early and growth stages.Since our debut, we have backed over 530 fast-growing and innovative companies. Over 200 of our portfolio companies have achieved exits through IPOs at the NYSE, NASDAQ, HKEX, Shanghai Stock Exchange, or Shenzhen Stock Exchange, or through M&A or other means. There are also over 70 portfolio companies that have achieved unicorn or super unicorn status.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series B, Series A, Series C
- China, United States, Hong Kong
Portfolio highlights
- Yanshengchao — Room A204-1, Floor 2, Building 2, Yard 9, Yike Road Life Science Park, Changping District Beijing China
- Minghui Pharmaceutical — Minghui Pharmaceutical is a biopharmaceutical business that specializes in immunology and oncology medicines for unmet needs.
- Huimei Technology — Huimei Technology is a National high-tech enterprise that offers medical artificial intelligence solutions.
Founded in 2005, Hillhouse is a leading global investment management firm, active across public equity, private equity, real estate and private credit. The firm invests over a long-term horizon and partners with exceptional entrepreneurs to deliver sustainable value creation for quality companies.Hillhouse is a full life-cycle private equityfirm, investing for the long term across opportunities in the healthcare, business services, consumer, and industrials sectors. The firm manages capital on behalf of global institutions such as non-profit foundations, endowments, and pensions.
Show more
Investment focus
- Biotechnology, Health Care, Software
- Series B, Series A, Series C
- China, United States, Singapore
Portfolio highlights
- Sainte — Sainte is a company which provides professional nutritional solutions for babies with different nutritional needs
- Vita Dynamics — Vita Dynamics involves learning through real-world interactions by developing robots that can physically engage with their environment, they can adapt more naturally and efficiently.
- Horizon Continental Technology — Horizon Continental Technology is a joint venture between Continental Group and Horizon Robotics
Shenzhen EFUNG Investment Management Enterprise L. P. is one of China's earliest institutions investing in professional biomedical industries. Their strong research team and great investment returns made us won 'The Most Pioneering VC Institution” 'The Most Dynamic Pharmaceutical VC Institution in China' and 'The Top Ten VCInstitutions in Shenzhen'. With this influence, EFUNG has drawn a lot of attention from the medical and life science industry. And it is interviewed by Nature, which is the most authoritative science magazine in the world. Over a decade of years, they have been focusing on the medical and health industry, especially the VC and PE investment business of novel drugs and high-end medical devices. The mission of EFUNG is to drive the industrialization of medical researches by capital and to gain rich returns to investors. EFUNG has deeply screened and invested in more than 20 domestic and international premium enterprises, such as Chipscreen Biosciences, Frontier Biotechnologies, Ascentage Pharma, Lifotronic, Aridis Pharmaceuticals, and Centrexion.
Show more
Investment focus
- Biotechnology, Health Care, Pharmaceutical
- Series A, Series C, Series B
- China, United States, India
Portfolio highlights
- QureBio — QureBio focuses on the research and development of innovative macromolecular biopharmaceuticals. Its goal is to develop new therapeutic drugs for the treatment of refractory cancer, autoimmune diseases, and metabolic diseases in China and the world to benefit patients. QureBio has multiple technology platforms for antibody drug developmentincluding phage display technology platforms and hybridoma antibodies technology platform and monoclonal antibody platform.The company was founded in 2017 and is based in Pudong District, Shanghai.
- Pleryon Therapeutics — Innovations in biofunctional polymers
- Tingsheng Technology — TINGSN develops Intracardiac echocardiography (ICE) catheter imaging technology designed to treat cardiac arrhythmia. In addition to ICE products, the company has developed its own heart internal catheter positioning and software algorithms and is developing China first computer surgical simulator for cardiac electrophysiology based on digitalheart model.
Huagai Capital is a private equity investment firm that invests in start-up or growth companies in the areas of healthcare, TMT, and culture.
Show more
Investment focus
- Health Care, Biotechnology, Medical
- Series A, Series B, Seed
- China, United States, Germany
Portfolio highlights
- ViGeneron — ViGeneron is dedicated to developing innovative gene therapies to treat ophthalmic diseases with high unmet medical need, as well as partnering with leading biopharmaceutical players in other disease areas. The company’s pipeline is built on two proprietary adeno-associated virus (AAV) technology platforms. The first, vgAAV gene therapy vectorplatform, allows superior transduction efficiency and intravitreal, less invasive treatment administration. The second, REVeRT vector platform, targets diseases caused by mutations in large genes. Privately-owned ViGeneron was founded in 2017 by a seasoned team with in-depth experience in AAV vector technology and clinical ophthalmic gene therapy programs and is located in Munich, Germany.
- Moyang Biotechnology — Moyang Biotechnology specializes in the development and consulting services of medical biomaterials for beauty sector.
- Index Technology — Index Technology is a company that specializes in applying artificial intelligence technology to electronic design and production. Index Technology uses generative AI technology to optimize the traditional R&D process for electrical devices, and it offers automated generation services ranging from product requirements to PCBA manufacturingdesigns and supporting embedded programs.
ULTIMA is an investment management firm.
Show more
Investment focus
- Hardware, Software, Agriculture
- Angel, Series A
- China
Portfolio highlights
- Maimai — Maimai provides software and hardware smart care solutions for middle-to-high-end institutions, senior citizens, communities and home care.
- Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
Vinno Capital focuses on early-stage venture investments in ICT and healthcare-related fields.
Show more
Investment focus
- Manufacturing, Semiconductor, Hardware
- Series A, Seed, Series B
- China, United States
Portfolio highlights
- Huachen Core Light — Huachen Core Light is a semiconductor technology company that produces and manufactures optical communications and laser chips.
- Beijing Ruidaen Technology Co. — Beijing Ruidaen Technology Co. is a manufacturer of target detection, radio interference, and laser electronic series.
- Northern Hemisphere Technology — Northern Hemisphere Technology is a high-tech company specializing in automotive-grade one-piece molded inductors. Northern Hemisphere focuses on high-performance and high-quality products, uses technology to serve customers and the market.
CD Capital is a venture capital firm specialized in life sciences and medical technology. They are currently managing both RMB and USD funds with total size of $600M. CD Capital is operated by a professional team with diversified and profound industry backgrounds. They have made over 40 investments with high growth potential and earned a reputationas a premier venture capital firm with main focus on China healthcare industry. With broad network around China and the world, they have been able to seize the global trend, capture investment opportunities as well as help to define the future for China healthcare industry. Ultimately, they strive to grow best-in-class companies and deliver solid financial return to their investors.
Show more
Investment focus
- Health Care, Biotechnology, Medical Device
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Healingovation — Healingovation is a med-tech company that specializes in the development and manufacturing of surgical robots, intelligent diagnosis and treatment equipment.
- Greenon Biotech — Greenon Biotech specializes in the research, development, production, and promotion of alternative antibiotic preparations for animals, which primarily include bacteriophages, probiotics, plant extracts, novel acid preparations, high-efficiency disinfectants, and so on.
- Qihe Biotech — Qihe Biotech develops novel genome editing technologies with an emphasis on making them autonomous and programmable.
WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable companies in the pharmaceutical, biotech and medical device industries worldwide to advance discoveries and deliver groundbreaking treatments to patients. As an innovation-driven and customer-focused company, WuXi AppTec helps our partners improve theproductivity of advancing healthcare products through cost-effective and efficient solutions,With industry-leading capabilities such as R&D and manufacturing for small molecule drugs, cell and gene therapies, and testing for medical devices, WuXi AppTec's open-access platform is enabling more than 3,900 collaborators from over 30 countries to improve the health of those in need – and to realize our vision that "every drug can be made and every disease can be treated".
Show more
Investment focus
- Biotechnology, Pharmaceutical, Health Care
- Series A, Series B, Series C
- United States, China, Israel
Portfolio highlights
- D3 Bio — D3 Bio is a globally focused biotechnology company focusing on developing and registration of innovative medicines in oncology and immunology. At D3 Bio, our new medicine development approach is fundamentally differentiated. We do not just only start with science in the lab. First, we pinpoint the greatest unmet patient and market needs – whereexisting standard-of-care approaches yield unsatisfactory clinical outcomes. Then we take those insights into the lab to guide the identification of fit for purpose science and technology and define our drug development path.
- ShouTi — ShouTi specializes in the discovery and development of drugs against a type of targets called GPCR. The company develops drugs focused on novel small molecules for multiple unmet medical needs. ShouTi is currently operating in Stealth mode.
- Bioyond Tech — Bioyond Tech utilizes robotics and artificial intelligence technology to provide a new generation of modular products and automation solutions for the life sciences sector.
CITIC Capital Holdings is an alternative investment management and advisory company headquartered in China.
Show more
Investment focus
- Manufacturing, Health Care, E-Commerce
- Series A, Series B, Series C
- China, United States, Japan
Portfolio highlights
- Xiaohongshu — Xiaohongshu is a lifestyle-sharing platform for users to share positive energy and good life through the sharing of text, pictures, and videos. Xiaohongshu offers an overseas shopping tip app. Xiaohongshu started its business by helping overseas travelers to draft a shopping list before they hit the roads. But with the aggregation of more UGCcontent, the service is transforming into a community for those who are passionate about fashion and shopping and want to know more about these fields even though they do not have overseas traveling plans on their schedules.
- Healthy Tree — Healthy Tree is a comprehensive solution provider for self-medication devices.
- Regional Fish — Regional Fish provides seed, seedlings, aquaculture methods and fisheries services.
MiraclePlus invests in and accelerates early-stage startups. MiraclePlus assists startups in developing products that are good enough to succeed in the market. MiraclePlus' acceleration program works with the founders to get each team in top shape so that they can present to thousands of investors on Demo Day.
Show more
Investment focus
- Artificial Intelligence, Software, Information Technology
- Seed, Angel, Pre-Seed
- China, United States, Singapore
Portfolio highlights
- TestSprite — AI powered fully automated end-to-end testing solutions to help enterprises launch their products faster.
- Excellent Vision — Excellent Vision is a spatial intelligence company focused to transforming video creation into a 4D world model, enabling AI big models to grasp, generate, and reason about 4D space.
- Gongji Technology — Gongji Technology is an idle computing power sharing platform that combines distributed computing power with leading scheduling techniques to address elastic computing power requirements.
ZSVC is a Chinese venture capital firm specialized in seed and early stage investments.
Show more
Investment focus
- Manufacturing, Medical, Health Care
- Series A, Seed, Series B
- China, United States, India
Portfolio highlights
- Micot — Micot is a new molecular entity drug developer for peptides, dedicated to the development of innovative drugs, multi- and protein-based innovative biopharmaceuticals, vaccines and biomolecular drug delivery systems and products, and for drug screening and biopharmaceutical research. The technology combines to provide users with Bio-Res-Deliv, abiological macromolecular respiratory drug delivery system, suitable for the treatment of cardiovascular diseases, metabolic diseases, liver diseases and the like.
- Deruicore — Deruicore is an integrated research and development based manufacturing company.
- Zhisheng Bio — Zhisheng Bio specialzies in product research and development, and market transformation of biopharmaceutical products.
Linear Capital focuses on investment projects in the fields of Data Application, Data Infrastructure and cutting-edge technology applications. they believe that cutting-edge technology is the primary productive force, and they are committed to becoming an important promoter of cutting-edge technology landing industries, realizing FrontierTechnology,
Show more
Investment focus
- Software, Artificial Intelligence, Biotechnology
- Seed, Angel, Series A
- China, Germany, Hong Kong
Portfolio highlights
- Bot Auto — Bot Auto develops and operates autonomous trucks for middle-mile freight.
- TARS — Zhihang Zhong is a prominent researcher in the field of artificial intelligence, particularly known for his work on integrating spatial perception and reasoning into AI systems.
- NewPro — NewPro is in the process of increasing production and establishing regulations for lactoferrin raw materials, with the goal of bringing the product to market as quickly as feasible.
Legend Capital, a subsidiary of Legend Holdings Ltd., started its vintage year in April, 2001 with a mission to become a top-notch and the most respected venture capital investment manager in China.Managing up to US$700 million across four funds, Legend Capital focuses on driving high-growth ventures with operations substantially based in Chinaor on markets related to China.Legend Capital mainly invests in early stage IT companies, specifically, in sectors of network applications and services, outsourcing and professional services, Infrastructure (IC design/key components), and mid-market growth stage companies in the fields of consumer goods, clean technology, health care, equipment manufacturing and modern services.Among over 60 portfolio companies are Joyo.com (acquired by Amazon.com), SinoCom (0299.HK), Solarfun Power (Nasdaq: SOLF), Spreadtrum Communications (Nasdaq: SPRD), China Sunshine Paper (2002.HK), and VanceInfo (NYSE:VIT), Eyang (0117.HK), etc.As an active investor, Legend Capital provides its portfolio companies extensive business resources and tailored services to assist with business development, company image building, and other critical company building activities on Chinese market so as to add value and maximize returns. Legend Capital is proud and thankful that it has the opportunity to blaze a trail with its innovative practice for China's venture capital industry.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series B, Series A, Series C
- China, United States, South Korea
Portfolio highlights
- Obita — Obita is a B2B financial network that offers stablecoin-driven transactions for enterprises, merchants, and fintechs.
- Elf Life — Elf Life is a medical device developer specializing in the design, development, and production of innovative healthcare technologies aimed at improving patient outcomes and enhancing the quality of medical care.
- X Square — X Square is a company focused on developing universal embodied large models for robots, aiming to create a universal brain-cerebellum system that offers comprehensive capabilities from perception to action.
Entrepreneurship Relay Group manages a fund of more than 4 billion yuan, directly or indirectly.
Show more
Investment focus
- Manufacturing, Software, Electronics
- Series A, Funding Round, Angel
- China
Portfolio highlights
- Songying Technology — Songying Technology focuses on the research and development of cloud-native real-time 3D engines and graphics collaboration platforms.
- Spectral Domain Technology — Spectral Domain Technology is a provider of 5G low-orbit broadband terminals, supplying operators, industrial Internet companies, satellite Internet, and government and enterprise customers with ocean communication needs.
- Optical Standard Technology — Optical Standard Technology focuses on the design and manufacture of optical computing chips and optical computing boards for use in scenarios requiring large amounts of AI computing power, such as large model reasoning and training, autonomous driving, smart cities, quantitative finance, AI security.
Suzhou Industrial Park Bioventure Investment Management Limited (Bioventure) was established in September 2013. Bioventure its first element of the new bio-industry funds 540 million yuan fund size. Bioventure specialize in the field of life sciences in the early stages of the venture capital investments as having high strength and growth, greaterdevelopment space, excellent management team, biotechnology, drug discovery, medical devices and healthcare services companies, and provide capital, management , operation and other aspects of post-investment support and services.Bioventure brought together senior investment professionals team with bio-pharmaceutical industry investment experience, strong fund management, entrepreneurship and venture capital and operating experience in business, have a deep understanding of the domestic and foreign markets, capable of its forward-looking international perspective and extensive The industry has the potential resources to help innovative companies grow rapidly and gain greater success, while giving fund investors bring considerable returns.Suzhou Industrial Park, the core investor BioBay has the country's best medical and pharmaceutical incubator function, use the platform, the project team has great resources and industrial service advantages, Yuan-sheng venture has successfully invested in 20 projects have been cast projects in their own development and follow-up financing, has made outstanding achievements in the industry for all to see, and won the Venture's trust and praise.By focusing and extensive industry resources, Bioventure determined to become one of China's most successful medical and pharmaceutical venture fund. Bioventure expectations and in the medical and pharmaceutical industry where there joint venture development cooperation.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United States, Taiwan
Portfolio highlights
- Libo Biotech — Libo Biotech is a cutting-edge biotechnology company dedicated to the discovery and development of innovative small molecule therapeutics that specifically target RNA.
- Yanshengchao — Room A204-1, Floor 2, Building 2, Yard 9, Yike Road Life Science Park, Changping District Beijing China
- Hongxin Biology — Hongxin Bio is an mRNA drug developer, focusing on nucleic acid drug delivery and RNA drug development.
Dalton Venture is a fund management company that specializes in early stage investment and industrial mergers and acquisitions in the field of big health.
Show more
Investment focus
- Health Care, Medical, Medical Device
- Seed, Series A, Series B
- India, China, Canada
Portfolio highlights
- Astribot — Astribot is a developer of consumer humanoid robots and integrated bionic robots.
- Yuantian Bio — Yuantian Bio is a biotechnology company specializing in enzymatic regeneration and commercial plastic PET applications. They have achieved low-cost fermentation preparation of over 10 enzyme preparations and large-scale biochemical product preparation.
- Yuetong Eye Clinic — Yuetong Eye Clinic is a medical institution that provides myopia surgery for adults and myopia prevention and control for adolescents. It is a medical institution focusing on adult myopia surgery and adolescent myopia prevention and control.
Tianjin Venture Capital is an investment firm.
Show more
Investment focus
- Manufacturing, Information Technology, Health Care
- Funding Round, Seed, Series A
- China, United States
Portfolio highlights
- Mech-Mind Robotics — Mech-Mind is dedicated to giving intelligence to industrial robots. Through core technologies such as machine vision (2D/3D), advanced programming models, fast environment awareness, intelligent decision making, and autonomous path planning, robots will no longer be a clumsy machine that can only repeat actions, but become available toeveryone and available everywhere. Smart helper. The company's core products are high-performance 3D cameras, visual AI algorithms and software, robot motion algorithms and software, and can provide reference designs and field services for a variety of typical applications. Mecamand's complete solution enables robot manufacturers and integrators to quickly upgrade their artificial intelligence capabilities to perform applications such as disordered object capture, visual guided unraveling, mixed palletizing, and precision positioning assembly.
- Xingneng Xuanguang — Xingneng Xuanguang is a fusion energy company that specializes in the development of advanced field reverse magnetic mirror fusion path technology.
- Innovec Biotherapeutics — Innovec Biotherapeutics Specialized in gene therapy technology and medication development.
Hillhouse Venture Capital is an investment institution established by Hillhouse Capital that focuses on investing in early-stage startups.
Show more
Investment focus
- Manufacturing, Biotechnology, Health Care
- Series A, Series B, Seed
- China, Singapore, Norway
Portfolio highlights
- TARS — Zhihang Zhong is a prominent researcher in the field of artificial intelligence, particularly known for his work on integrating spatial perception and reasoning into AI systems.
- Deepin Technology — Deepin Technology is a company that utilizes artificial intelligence, quantum chemistry, and high-throughput experiment technologies to enhance the efficiency and workflow of chemical material innovation. it offers efficient R&D solutions for chemical materials, aiming to solve lab bottlenecks, promote innovative research, and enhance customervalue.
- Hecheng New Materials Technology — Hecheng New Materials Technology is a manufacturing company offering bearing electrical corrosion and electrical insulation solutions.
K2VC (Xianfeng Evergreen) was founded in 2010, focused on early stage investment in technology start-ups in China, focus on promoting change and technological progress, innovative business models and lifestyles.
Show more
Investment focus
- E-Commerce, Manufacturing, Biotechnology
- Series A, Seed, Angel
- China, United States, Japan
Portfolio highlights
- Hanfa Changkong — Hanfa Changkong is a developer of civilian small and medium-power aircraft engines, precisely targeting the domestic civilian low- and medium-altitude aviation propulsion market
- YolTech Therapeutics — Yaotang (Shanghai) Biotechnology is a high-tech biotechnology company focusing on developing a new generation of mRNA drugs and gene editing drugs by combining mRNA in vivo delivery technology and gene editing technology. Through the continuous development and optimization of CRISPR, base editing and other new-generation gene editing tools, andinnovative improvements to the next-generation mRNA production platform and lipid nanocarrier assembly process, Yaotang Bio is committed to developing treatments for genetic diseases and cardiovascular disease.
- Hangmo Technology — Hangmo Technology is a developer of advanced flexible robotics technology, primarily focused on the design and engineering of highly integrated robotic systems. The company specializes in creating compact, adaptable, and intelligent robotic solutions that can be applied across various industries, including manufacturing, healthcare, and serviceautomation
Tsinghua Capital is an investment firm.
Show more
Investment focus
- Manufacturing, Artificial Intelligence, Biotechnology
- Seed, Angel, Series A
- China, Australia
Portfolio highlights
- PureblueAI — PureblueAI is an AI-powered digital workforce platform operator specializing in enterprise marketing scenarios.
- Lingyu Intelligence — Lingyu Intelligence engages in the manufacturing and sales of industrial robots, intelligent robots and service consumer robots.
- Weizhen New Materials — Weizhen New Materials is a company focused on the research and development of new materials technologies, primarily focusing on the development and application of high-performance modified nylon materials and multifunctional composite materials.
Sherpa Venture Capital is an investment firm that focuses on the investment and cultivation of the Pharmaceutical and Biotech industry. It also specializes in the investment and management of sector leaders and innovators within the Pharma, GeneTech, MedTech, Medical services, and various sub-sectors, where they have established robust portfoliosources, lasting value-adding cooperations and relationships, as well as mature all-cycle services with key resources. It was founded in 2018 and is headquartered in Beijing, China.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- China, United States, Kenya
Portfolio highlights
- AusperBio — AusperBio is a Phase II clinical-stage biopharmaceutical company dedicated to transforming hepatitis B treatment for a cure and advancing oligonucleotide therapeutics. Leveraging their innovative and proprietary Med-Oligo™ ASO platform with effective targeted delivery technologies, AusperBio strives to unleash the power of ASO therapeutics to treata wide range of diseases, including viral infections, metabolic conditions, genetic disorders, and immune diseases.
- PAQ Therapeutics — PAQ Therapeutics is developing KRAS degraders for deadly cancers without good treatment options.
- Archimedes Vascular — Archimedes Vascular operates as a medical device company, that treat patients with severe hypertension.
Lenovo Capital and Incubator Group is an accelerator and venture capital firm.
Show more
Investment focus
- Manufacturing, Artificial Intelligence, Software
- Series A, Series B, Seed
- China, Hong Kong, United States
Portfolio highlights
- DexForce — DexForce offers an AI-enabled robot with integrated 3D vision cameras, and software and hardware solutions for manufacturing robots.
- Zhiran Medical — Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders using high-throughput, flexible brain-computer interface technology.
- West Lake Yanshan Technology — West Lake Yanshan Technology is a micro-LED company that focuses on the manufacturing and production of full-color display chips.
Highlight Capital is an investment firm dedicated to support healthcare companies to generate robust and sustained growth prospect.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United States, Portugal
Portfolio highlights
- VelaVigo — VelaVigo is a start-up company engaged in macromolecular biopharmaceuticals.
- Qianxun Intelligence — Qianxun Intelligence is an intelligent technology developer that offers software development, intelligent robot research and development, AI hardware sales, AI application software development, information system integration services, and Internet sales.
- E-nitiate Biopharmaceuticals — E-nitiate Biopharmaceuticals is committed to the development of innovative drugs for autoimmune diseases, through independent research and development, and strategic collaborations, to address unmet medical needs and to improve the quality of human life.
Yida China Holdings provides park development, park operation, construction, property management, landscaping, and decoration services. Their customers inquiries are addressed through phone, email, and online applications.
Show more
Investment focus
- Manufacturing, Semiconductor, Biotechnology
- Series A, Series B, Funding Round
- China, United States
Portfolio highlights
- Nasikey — Nasikey specializes in the research, development, production, and sales of core components for semiconductor equipment.
- Shengtai Nengke — Sunpower Group is an enterprise driven by green investment, based and supported by manufacturing and engineering services, and driven by R&D and innovation. Sunpower Group is headquartered in Nanjing, Jiangning.
- Atlan Technology — Atlan Technology focuses on the research and development, production and sales of composite high-performance fiber materials.
Puhua Capital is an equity investment firm that focuses on early and middle project.
Puhua Capital provides the required resources and management experience for the invested enterprise, investing funds and more resources and wisdom. Puhua Capital has invested nearly 300 excellent start-ups.
Show more
Investment focus
- Health Care, Medical, Manufacturing
- Series A, Series B, Seed
- China, United Kingdom, United States
Portfolio highlights
- Kangweijian Bio — Kangweijian Bio is a health food manufacturer and distributor dedicated to delivering safe, high-quality products and services across global markets, specializing in food and cosmetic raw materials, health food ingredients, pharmaceutical excipients, and animal nutrition.
- LuMing Robotics — LuMing Robotics is a developer of intelligent robots. LuMing Robotics focuses on the field of embodied intelligent robots, and its business covers intelligent robot R&D and sales, artificial intelligence algorithm development, etc.
- Rongrui Technology — Rongrui Technology is an industrial enzyme developer, involved in industrial enzyme research and development; technical services, technology development, technology consulting, technology exchange, technology transfer, and technology promotion.
Innoangel Fund is an investment firm that invests in early stage companies.
Show more
Investment focus
- Artificial Intelligence, Manufacturing, Robotics
- Angel, Seed, Series A
- China, Canada, Hong Kong
Portfolio highlights
- PureblueAI — PureblueAI is an AI-powered digital workforce platform operator specializing in enterprise marketing scenarios.
- Lingyu Intelligence — Lingyu Intelligence engages in the manufacturing and sales of industrial robots, intelligent robots and service consumer robots.
- Weizhen New Materials — Weizhen New Materials is a company focused on the research and development of new materials technologies, primarily focusing on the development and application of high-performance modified nylon materials and multifunctional composite materials.
Huimei Capital primarily seeks investment in the medical and healthcare ecosystem in a multi-dimensional and three-dimensional manner. It is committed to building a professional investment platform with international vision and local execution, helping early and growing medical and health companies to grow rapidly.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- China, United States, Japan
Portfolio highlights
- Sniper Medical Technology — Sniper develops accurate and intelligent molecular diagnostic solutions. Taking the next-generation fully automatic digital PCR as a breakthrough, the company has developed a droplet generation method with global independent intellectual property rights - Vibrant Injection technology and created a new path of chip-free droplet generationtechnology. It solves the pain points of high cost and complicated operation of microfluidic technology in practical application and is expected to bring subversive innovation in the field of refined medical testing.
- Xushui Internet — Xushui Internet provides image equipment monitoring, operation, and maintenance cloud services, large-scale equipment IoT management system, digital integration services for hospital-wide equipment, and remote collaborative image inspection system.
- Chengdu Pukang Biotechnology Co. — Chengdu Pukang Biotechnology Co., Ltd specializes in the development, production, and supply of high-purity single molecular PEG series derivatives, polypeptide long-acting drug side chains, and their intermediates. The company focuses on serving the pharmaceutical industry with a range of chemical supplies that are crucial for drug development andmanufacturing processes. With a professional R&D team, Chengdu Pukang Biotechnology is dedicated to advancing pharmaceutical intermediates technology and providing solutions that meet the evolving needs of the healthcare sector. The company's commitment to research and development is evident in its continuous efforts to innovate and improve its product offerings to support the pharmaceutical industry.
Gaw Capital Partners is a positioned private equity fund management company that focuses in real estate markets in greater China and other high barrier-to-entry markets globally. Their services includes gateway real estate funds, separate account investments, venture capital, private equity investment and credit investments.
Show more
Investment focus
- Real Estate, Property Management, Hospitality
- Series A, Series C, Seed
- China, Singapore, United States
Portfolio highlights
- Blackpanda — Asia's premier digital forensics and cyber incident response firm.
- SARELLY SARELLY — SARELLY SARELLY is a gender-neutral and transparent fashion brand, offering affordable luxury to the Hispanic Gen Z community.
- NPX Point Avenue — NPX Point Avenue is an education technology company focused on the fast-growing K-12 private international school market and K-12 after-school training market.
Eight Roads has a 50+ year history of investing and partners with game-changing technology and healthcare companies, supporting them as they scale to become global leaders.
Show more
Investment focus
- Software, Health Care, Information Technology
- Series B, Series A, Series C
- United States, China, India
Portfolio highlights
- Swan — Use Swan's APIs to embed white-labeled banking features like accounts, cards, and IBANs into your workflows and UX.
- Safe Security — Incubated from IIT Bombay in 2012 and headquartered in Palo Alto, Lucideus has over 200 customers worldwide with an average NPS of 73.Backed by John Chambers and senior executives from SoftBank, Sequoia, PayPal, Adobe and McKinsey & Co., it was also one of the Top 5 Contributors to the NVD of the U.S. Government in 2019.Its platform, SAFE,allows an organization to get an Enterprise-Wide, Objective, Consistent & Real-Time Visibility of it’s overall Cyber Risk Posture. Built on supervised machine learning engine, SAFE gives an output both in the form of a breach likelihood score (between 0-5) and the $ value Risk the organization is sitting on, along with providing prioritized actionable insights based on technical cybersecurity signals, external threat intelligence, and business context of what and where are the "weakest links" across people, process and technology.The company, since 2018, has also been working with MIT for a joint research and development on the SAFE Scoring Algorithm and has received several awards including the Morgan Stanley CTO Innovation Award 2019.
- BlissClub — BlissClub is the community's first women's activewear brand.
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Show more
Investment focus
- Biotechnology, Health Care, Medical
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- Enchannel — Enchannel Medical is a global innovation platform that focuses on electrophysiology and provides atrial fibrillation treatment solution around "3D mapping + PFA ablation".
- Kriya Therapeutics — Kriya is a biopharmaceutical company developing gene therapy to address common diseases that impact millions of people worldwide. Learn more.
- Heyuan Medical Devices — Heyuan Medical Devices serves as an enterprise service provider, offering specialized medical equipment and support solutions tailored to the needs of healthcare institutions and organizations
Matrix Partners China builds long-term relationships with entrepreneurs and helps them build significant, industry-leading companies.Since its inception in 1977, Matrix Partners China has made hundreds of investments and played an active role in the development of many successful businesses, 50 of which went on to IPO, and 75 of which have goneon to profitable M&A events. The firm consistently ranks in the top venture firms in terms of returns to its investors.Matrix Partners China combines local knowledge with global experience and vision. Its team consists of both former entrepreneurs and experienced investors. Its past successes include Focus Media, Eachnet, and Baidu, among others. The company invests across multiple sectors and stages.
Show more
Investment focus
- Health Care, Biotechnology, Software
- Series A, Series B, Series C
- China, United States, Hong Kong
Portfolio highlights
- Sand.ai — Sand AI is an AI company that focuses on producing videos.
- TOYA — TOYA specializes in the production of ultra-fine copper and copper alloy conductors.
- Stablestocks Lab — Stablestocks Lab focuses on the on-chain stock ecosystem, aiming to bridge trillions of equity liquidity into DeFi.
ASBV focuses on early and mid-term venture capital investments.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Seed, Series A, Angel
- China, Australia, Hong Kong
Portfolio highlights
- Kaiyue Life — Kaiyue Life focuses on small molecule medication research & development for the treatment of human Ras mutant solid tumours.
- Boundary Intelligent Control — Boundary Intelligent is specialized in creating airborne systems, such as flight control systems, that satisfy the needs of civil aircraft, as well as enhancing the ecology of the civil aviation industry and constructing aircraft perception, navigation, decision-making, and planning capabilities.
- Longyue Mechanical and Electrical Technology — Longyue Mechanical and Electrical Technology engaged in technologies, strengthened linkages, and provided commercial aircraft services.
Haitang Fund is a venture capital fund jointly established by Tianjin University alumni entrepreneurs and other alumni and entrepreneurs.
Show more
Investment focus
- Manufacturing, Biotechnology, Medical
- Seed, Series A, Funding Round
- China
Portfolio highlights
- Scan3D — Scan3D is a high-tech enterprise focusing on the research and development of new materials and intelligent equipment.
- Tianhai Junkang — Tianhai Junkang is an enterprise focusing on the sales of Class II medical devices and related technical services.
- Tianhesheng New Materials — Tianhesheng is a new materials technology company specializing in the development, production, and sales of boron isotope products. They plan to use their latest funding round to enhance research and development as well as expand market growth.
Med-Fine Capital is a venture capital firm focusing on early stage investments in China healthcare industry. The company is headquartered in Shanghai with offices in Beijing and Shenzhen.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Seed, Series B
- China, United States
Portfolio highlights
- BV Laser — BV Laser is a manufacturer of medical beauty equipment.
- Allink Biotherapeutics — Allink Biotherapeutics is a biopharmaceutical company that focuses on oncology and immunological treatment.
- Excalipoint Therapetics — Excalipoint Therapeutics is a Private limited company.
Bits x Bites is a food tech VC that invests in early-stage startups tackling global food system challenges. It targets companies innovating across the food supply chain, from farming, production, distribution, and logistics, to consumer goods and food services.
Show more
Investment focus
- Biotechnology, Food and Beverage, Food Processing
- Series A, Seed, Series B
- China, Israel, Singapore
Portfolio highlights
- Cataya Bio — Cataya Bio (Shanghai) Co., Ltd. is a product company powered by an advanced engineering biology platform and biomanufacturing. We engineer microbes and develop clean fermentation processes to manufacture products of high purity, at low cost, and in a sustainable way. We strive to help the world to transition away from petroleum and addressimportant global issues in environmental preservation, carbon emission and climate change.
- Ketai Bio — Ketai Bio is a synthetic biology company dedicated to the R&D, production and sales of high value-added bio-based products.
- Changjin Biotechnology — Changjin Biotechnology engages in the research, development, and industrialization of microbial synthetic proteins.
Supporting the next generation of entpreneurs in enterprise, healthcare, and consumer with disruptive potential.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Series A, Series B, Seed
- China, United States, South Korea
Portfolio highlights
- iRegene — iRegene researches and develops pharmaceutical therapy for neurodegenerative and rare diseases.
- Wala English — Wala English is a provider of comprehensive full-process AI contextual learning services, leveraging artificial intelligence to deliver personalized, immersive language learning experiences that adapt to each learner’s needs, context, and progress throughout their educational journey.
- Hertz Life Science Technology — Hertz Life Science Technology uses virus-like particle VLPs technology to develop animal and human vaccines.The company has several underlying core patented technologies and has established a stable and efficient research and development platform based on the Jiyin Biomedical Transformation (Greater Bay Area) base, and actively promotes theresearch and development of vaccines.At present, the company has carried out extensive and in-depth cooperation with large enterprises such as Qingdao Yibang and Wen's Group, and its R&D strength has been highly recognized by peers and upstream and downstream enterprises.
Discover BV.AI, a premium two-letter domain for AI innovation and vision. Perfect for startups and investors in AI-driven solutions across various industries, including healthcare, finance, security, and marketing. Invest in the future of AI with this ultra-short, flexible branding opportunity.
Show more
Investment focus
- Artificial Intelligence, Health Care, Biotechnology
- Series A, Seed, Series B
- China, United States, Germany
Portfolio highlights
- InsForge — InsForge is the Agent-Native Supabase Alternative. We are building the features of Supabase in an AI-native way, enabling AI agents to build and manage full-stack applications autonomously.
- CoreSpeed — CoreSpeed provides a platform for building, launching, and earning from AI agents. The service includes the CoreSpeed SDK, which handles infrastructure tasks like payment, storage, and authentication. Developers can use Zypher Agent, a general-purpose tool, to create custom AI agents. The platform supports industry-standard protocols for agentcommunication and interaction. Users can list their AI agents in the Agent Store for public access and usage tracking. The AI Gateway manages usage costs and model billing, while the AI App Router creates separate environments for each user. It also supports scaling and monitoring to help developers manage system performance.
- Zhiran Medical — Zhiran Medical is a medical technology company specializing in the precise detection and treatment of neurological disorders using high-throughput, flexible brain-computer interface technology.
BMC engaged in asset management, investment management and consulting.
Show more
Investment focus
- CAD, Medical, Computer
- Seed, Series B
- China
Portfolio highlights
- Bochuang Biotechnology — Bochuang Biotechnology is a cutting-edge medical repair product developer that specializes in the controllable electrochemical assembly of biomacromolecules. Bochuang Biotechnology is creating a line of high-end biological tissue functional membranes and derived medical device solutions.
- Jingyao Xinhui Semiconductor — Jingyao Xinhui Semiconductor is the indium phosphide optical chip manufacturer company.
- Suzhou Pelotin Biotechnology — Suzhou Pelotin Biotechnology is a research firm specializing in peptides, recombinant proteins, GE antibodies, and protein expression.
Starlight Capital provides investment and assistance to companies from the digital industry. It searches for businesses that are focusing on digital transformation and helps with its management. Starlight Capital is based in Shanghai, China.
Show more
Investment focus
- Manufacturing, Robotics, Software
- Series A, Series C, Series B
- China
Portfolio highlights
- Hailan Acoustics — Hailan Acoustics focuses on the research and development, production and sales of marine sensors and equipment.
- Wanxun Technology — Wanxun Technology is a service robot developer dedicated to flexible, dexterous and interactive service robots for industries and families.
- Kedian Intelligent Cloud — Kedian Intelligent Cloud is an innovative enterprise focusing on the field of industrial hemp.
Our team invests in early-stage digital health and consumer startups at CentreGold Capital.
Show more
Investment focus
- Medical Device, Artificial Intelligence, Internet
- Seed, Series A, Angel
- United States, China, Canada
Portfolio highlights
- Juix — Juix is a power bank rental service that allows people to charge their devices on the go.
- Virgo — Accelerate GI clinical trials with AI for endoscopy. Use video to automate workflows, improve standard of care, and accelerate results.
- WeBox — Saltalk is a virtual kitchen platform that focuses on Asian Authentic Food optimized for delivery services.
Danen Ventures is an early-stage venture capital firm that focuses on high-growth fields, such as information technology and internet, renewable energy and environmental, advanced manufacturing industry, biotechnology and medical science, and healthcare.
Show more
Investment focus
- B2B, Fashion, Medical
- Series A, Angel, Seed
- China, United States
Portfolio highlights
- CartaBio — CartaBio is an authorised spatial omics technology platform. CartaBio specializes in the creation of AI-integrated solutions for the biotech industry, including scission-accelerated fluorophore exchange and the multimodal CellBERT model.
- SynMetaBio — SynMetaBio is a company that develops synthetic biological materials, combining synthetic biology and material design. Their business modules include bio-based medical beauty, functional recombinant proteins, and medical aesthetic materials, including bionic bio-based leather.
- Meiyou Technology — Meiyou Technology is a DNA synthesizer developer focusing on enzymatic long-fragment DNA synthesis and splicing technology. They use high-throughput synthesizers to reduce DNA synthesis costs and offer gene design services for the biotechnology industry.
Shenzhen Oriental Fortune Capital Co Ltd. is a venture capital firm specializing investment in early venture, mid venture, late venture, emerging growth, Pre-IPO, mature, growth capital stage, mezzanine and new third board investments. The firm typically invests in financial services, telecommunication, new energy, consumer goods, medical treatmentand healthcare, life sciences, internet plus healthy lifestyle industry, logistics, energy technology, information technology, mobile innovation, media, movies and television, culture, pharmaceutical, biological medicine, renewable energy, retail, environmental protection business, consumption, new materials, new agriculture, advanced manufacturing, equipment manufacturing, culture, entertainment, and services. It seeks to invest in China focusing on Shenzhen, Shanghai, Beijing, Xi’an, and Wuhu. The firm also invests in Pearl River Delta region, Yangtze River Delta region, and Circum-Bohai-Sea region. For Pearl River Delta, it covers Guangzhou, Shenzhen, Foshan, Dongguan, Zhongshan, Zhuhai, Huizhou, Jiangmen, and Zhaoqing cities in China. For Yangtze River Delta, the firm covers Shanghai, Nanjing, Wuxi, Changzhou, Suzhou, Nantong, Yancheng, Yangzhou, Zhenjiang, Taizhou, Hangzhou, Ningbo, Jiaxing, Huzhou, Shaoxing, Jinhua, Zhoushan, Taizhou, Hefei, Wuhu, Ma’anshan, Tongling, Anqing, Chuzhou, Chizhou, and Xuancheng cities in China. For the Circum-Bohai-Sea region, it covers Beijing, Tianjin, Shenyang, Dalian, Qingdao, Dandong, Yingkou, Panjin, Fuxin, Huludao, Chaoyang, Shijiazhuang, Baoding, Tangshan, Qinhuangdao, Cangzhou, Langfang, Chengde, Zhangjiakou, Handan, Xingtai, Dongying, Yantai, Weifang, Weihai, Rizhao, and Binzhou cities in China. The firm prefers to invest 20% of its portfolio to early stage, 40% to expansion stage, and 40% to Pre-IPO stage. Shenzhen Oriental Fortune Capital Co Ltd. was formed in November 2007 and is based in Shenzhen, China with offices in Shanghai, China; Beijing, China; and Wuhu, China.
Show more
Investment focus
- Software, Manufacturing, Information Technology
- Series A, Series B, Seed
- China, United States
Portfolio highlights
- Aiator — Aiator is an artificial intelligence product and technology solutions company focusing on industrial fields and biotechnology. Founded in 2010 by Silicon Valley Artificial Intelligence Scientist in Shenzhen Qianhai DreamWorks, the core members of the team are from the United States, the United Kingdom, Australia and Hong Kong. Currently, there arefour peacock talents and nearly 30 independent intellectual property rights. Weiai Intelligent is committed to carrying out AI empowerment services for enterprises, reducing costs and increasing efficiency.
- Qianxun Intelligence — Qianxun Intelligence is an intelligent technology developer that offers software development, intelligent robot research and development, AI hardware sales, AI application software development, information system integration services, and Internet sales.
- Gongjin Microelectronics — Gongjin Microelectronics develops and manufactures electronic components and semiconductor solutions for various industries.
Shunwei Capital is a venture capital fund that focuses on early to mid-stage investments in local internet industry. It specializes in incubation, startups, early to mid-stage, and growth capital investments. It seeks to invest in the technology, media, telecommunications, high technology, new media, games, internet finance, and rural area internetsectors. Their investors include sovereign wealth funds, fund of funds, university endowment funds, and family offices.
Show more
Investment focus
- Manufacturing, Software, Internet
- Series A, Series B, Series C
- China, India, United States
Portfolio highlights
- LibLib AI — LibLib AI is an AI image generation platform that provides cutting-edge content creation through multi-scenario and multi-dimensional applications and interactions. It is a subsidiary of Beijing Singularity Star Technology Co., Ltd.
- Huashen Ruili — Huashen Ruili is a manufacturer and retailer of auto parts. It focuses on the advancement of drive motor systems' dry brake-by-wire technology.
- Fanding International Group — Fanding International Group offers supply chain services by reducing logistics costs.
CDH Investments is an international alternative asset fund manager with over $27 billion of assets under management. CDH Investments was established in 2002 by the former private equity group of China International Capital Corporation and is managed by an experienced team of senior private equity professionals who have worked together for manyyears focusing all their professional time on investing in China. CDH has consistently delivered superior returns relative to industry peers and is well positioned to continue to generate superior returns due to the team's proven investment experience and expertise investing in China.
Show more
Investment focus
- Manufacturing, Health Care, Biotechnology
- Series A, Series B, Series C
- China, United States, Canada
Portfolio highlights
- ZSPepLib — ZSPepLib is a peptide lead drug developer, established in January 2017, coordinates Zhuzhou, Hunan. It is a platform-based company specializing in peptide lead drug discovery, focusing on the development, production, sales and new peptide drugs of the large-capacity peptide library. Screening R&D technical services.
- Kangweijian Bio — Kangweijian Bio is a health food manufacturer and distributor dedicated to delivering safe, high-quality products and services across global markets, specializing in food and cosmetic raw materials, health food ingredients, pharmaceutical excipients, and animal nutrition.
- Yizheng Biology — Yi Zheng Bio is a medical device developer. The company is mainly engaged in technology research and development and sales in the field of medical devices, providing medical device products to the medical industry.
Orient Securities Capital Investment is an private equity fund business platform.
Show more
Investment focus
- Manufacturing, Health Care, Medical
- Series A, Funding Round, Series B
- China
Portfolio highlights
- Picea Motion — Picea Motion is a precision harmonic drive company that specializes in the development and production of harmonic speed reducers.
- Xinhui Lianxin — Xinhui Lianxin is an electronic component manufacturer, mainly engaged in the manufacturing of special equipment for semiconductor devices, semiconductor discrete devices, power electronic components, integrated circuit manufacturing, integrated circuit chips and product manufacturing.
- Haifu Technology — Haifu Technology is a high-tech company specializing in automobile manufacturing and robotics.
Shenzhen Green Pine Capital Partners Co. Ltd. (“GPCP”) was established in 2007, with the investment team assembled in 2000. GPCP is one of the most time-honored Chinese VC companies that boast experience in areas such as biotech, new materials, new resources and AI, etc. Currently, GPCP manages assets over 15 billion RMB through 21 special fundsand have invested 7 billion RMB into 388 enterprises among which 14 are listed on NEEQ and 48 of them are either listed or acquired by listed companies, including BGI(300676.SZ), Aurora(600666.SH), Nationz Tech(300077.SZ), Foresee(002530.SZ), Qudian(NASDAQ:QD), etc. GPCP invested in the angel round of BGI (Beijing Genomics Institute), Royole, Kuang-Chi, Appotronics, BMF, C-one, Arrayed Materials and other star enterprises.GPCP is based in Shenzhen, with branches in Beijing, Shanghai and Guangzhou. GPCP also runs two GPI incubators and an incubator for overseas Chinese scientists who start businesses in China.
Show more
Investment focus
- Software, Artificial Intelligence, Manufacturing
- Series A, Series B, Angel
- China, United States, Canada
Portfolio highlights
- Sunrise — Sunrise is a high-performance GPU developer specializing in GPU research and development.
- Shanmu SHANMU — Shanmu SHANMU is a micro medical robot specialist who uses self-developed digital microfluidic chipsets and artificial intelligence algorithms. The robot can continuously check the metabolic components in urine, establishing a link between the user's health status and disease and intelligently establishing multiple disease management cycles.
- YolTech Therapeutics — Yaotang (Shanghai) Biotechnology is a high-tech biotechnology company focusing on developing a new generation of mRNA drugs and gene editing drugs by combining mRNA in vivo delivery technology and gene editing technology. Through the continuous development and optimization of CRISPR, base editing and other new-generation gene editing tools, andinnovative improvements to the next-generation mRNA production platform and lipid nanocarrier assembly process, Yaotang Bio is committed to developing treatments for genetic diseases and cardiovascular disease.
Zoo Capital is focusing on early-stage investments in technology, healthcare, and consumer companies.
Show more
Investment focus
- Artificial Intelligence, Software, Biotechnology
- Seed, Series A, Series B
- China, Hong Kong, United States
Portfolio highlights
- TabbyML — Tabby is an open-source AI coding assistant that empowers developers to code faster and smarter. Discover a self-contained alternative to GitHub Copilot, tailored for your development needs.
- Mol Breeding — Mol Breeding is a biotech firm that focuses on animal and plants molecular breeding technology R&D and services.
- Xingan Technology — Xingan Technology is a developer of SiC power semiconductor products.
BOHE Angel Fund is an investment Fund.
Show more
Investment focus
- Health Care, Medical, Biotechnology
- Angel, Series A, Seed
- China
Portfolio highlights
- QuarkMed — QuarkMed is a nuclear medicine clinical CRO service company.
- Tyligand Bioscience — Tyligand Bioscience is a biotechnology company that focuses on the discovery and development of small molecule therapeutics to help patients with cancer and autoimmune diseases. Tyligand's pharmaceuticals are designed to target and treat tumors and autoimmune disorders, enabling healthcare professionals to prescribe more effective medicine andimprove health outcomes.
- Yili Pharmaceutical — Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.
Investors by industry
Google
Marketplace
Hardware
Energy
Proptech
Health Care
Biotech
Artificial intelligence
Climate
Consumer
Community
Impact
Gaming
FinTech
EdTech
Sustainability
Venture Capital
Big Data
Web3
B2B
Financial Services
Finance
Infrastructure
Education
Photography
Payments
Food and Beverage
Video Games
Organic Food
Retail
Beauty
Publishing
Clean Energy
Real Estate
Manufacturing
Art
Music
Android
Internet
Enterprise Software
eSports
Franchise
Sports
Construction
Digital Media
Email
Medical
Social Network
Wellness
Social Media
Mobile
Legal
Local
Recruiting
Cannabis
Platforms
Fitness
Travel
Mobile Advertising
Biotechnology
Hospitality
Social
Automotive
Crowdfunding
Wine And Spirits
Medical Device
CleanTech
Transportation
Mobile Apps
InsurTech
Enterprise
LGBT
Fashion
Oil and Gas
Life Science
Theatre
Film
Non Profit
Renewable Energy
SaaS
Sporting Goods
Restaurants
Social Impact
Software
Celebrity
Cryptocurrency
Machine Learning
Agriculture (agtech)
Media (entertainment)
Facebook
Blockchain
Investors by country
United Kingdom
Canada
South Korea
Ireland
United States
New Zealand
India
Germany
Australia
Armenia
South Africa
Spain
Japan
Africa
China
Sri Lanka
Singapore
Qatar
Asia
Indonesia
Vietnam
Oceania
LATAM
Middle East
Europe
Saudi Arabia
Brazil
Bulgaria
Belize
Bahrain
Croatia
Georgia
Belarus
Hungary
Liechtenstein
Liberia
Lebanon
Mauritius
Peru
Norway
Israel
Malaysia
France
Mexico
Nicaragua
Jersey
Panama
Ghana
Morocco
Mali
Lithuania
Italy
Ethiopia
Philippines
Gibraltar
Kuwait
Malta
Myanmar
Sierra Leone
El Salvador
Uganda
Chile
Venezuela
Sweden
Slovenia
Poland
Uruguay
Ukraine
Egypt
Tajikistan
Puerto Rico
Portugal
Tunisia
Taiwan
Tanzania
Turkey
San Marino
Senegal
Finland
Togo
Uzbekistan
Serbia
Russian Federation
Zambia
Rwanda
Zimbabwe
Thailand
Costa Rica
Dominican Republic
Greece
Azerbaijan
Iceland
Nigeria
Bahamas
Namibia
Iraq
Barbados
Belgium
United Arab Emirates
Jamaica
Honduras
Estonia
Isle of Man
Bolivia
Bermuda
Luxembourg
Czech Republic
Pakistan
Denmark
Albania
Algeria
Hong Kong
Ecuador
Grenada
Jordan
Romania
Faroe Islands
Bangladesh
Kenya
Argentina
Kazakhstan
Cayman Islands
Cambodia
Austria
Oman
Latvia
Cyprus
Switzerland
Cameroon
Colombia
Guatemala
Marshall Islands
Seychelles
VC (Venture Capital) Funds in China by industry
Restaurants
Venture Capital
Film
Retail
Publishing
Financial Services
Real Estate
Cryptocurrency
Finance
Payments
Food and Beverage
Wine And Spirits
Organic Food
Video Games
Medical Device
Medical
Wellness
Internet
Social Media
Art
Manufacturing
Digital Media
Music
Blockchain
Mobile
Android
Non Profit
Legal
Social Network
Software
Local
Enterprise Software
Sports
eSports
Fitness
InsurTech
Travel
Automotive
Hospitality
Mobile Advertising
Recruiting
Platforms
FinTech
Biotechnology
Enterprise
Health Care
Biotech
EdTech
Climate
Energy
Sustainability
Proptech
SaaS
Crowdfunding
Marketplace
Community
Hardware
Gaming
Social
Infrastructure
Beauty
Fashion
Web3
B2B
Life Science
Sporting Goods
Photography
Big Data
Clean Energy
Education
Oil and Gas
Renewable Energy
Construction
Impact
Consumer
Artificial intelligence
Transportation
Agriculture (agtech)
Machine Learning
Media (entertainment)
CleanTech
Mobile Apps